Peer Review History
| Original SubmissionMay 21, 2021 |
|---|
|
PONE-D-21-16867The last stretch: Barriers to and facilitators of full immunization in NepalPLOS ONE Dear Dr. Paul, Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process. Please submit your revised manuscript by Oct 24 2021 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file. Please include the following items when submitting your revised manuscript:
If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter. If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: https://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols. Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols. We look forward to receiving your revised manuscript. Kind regards, Andy Stergachis, PhD Academic Editor PLOS ONE Journal Requirements: When submitting your revision, we need you to address these additional requirements. 1.Please ensure that your manuscript meets PLOS ONE's style requirements, including those for file naming. The PLOS ONE style templates can be found at https://journals.plos.org/plosone/s/file?id=wjVg/PLOSOne_formatting_sample_main_body.pdf and https://journals.plos.org/plosone/s/file?id=ba62/PLOSOne_formatting_sample_title_authors_affiliations.pdf Additional Editor Comments (if provided): Title: Missing is the target group, i.e., 'in children'. Consider adding to the title. Methods: Provide additional information on the characteristics of the geographical location of the study, such as population demographics and health burden, particularly in young children. Results: Why do some subheadings not include quotes from participants while most of the others do? Discussion: Strive to better organize as well as shorten its length. Limitations: Additional limitations are cited by a reviewer. [Note: HTML markup is below. Please do not edit.] Reviewers' comments: Reviewer's Responses to Questions Comments to the Author 1. Is the manuscript technically sound, and do the data support the conclusions? The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented. Reviewer #1: Partly Reviewer #2: Yes ********** 2. Has the statistical analysis been performed appropriately and rigorously? Reviewer #1: N/A Reviewer #2: Yes ********** 3. Have the authors made all data underlying the findings in their manuscript fully available? The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified. Reviewer #1: Yes Reviewer #2: Yes ********** 4. Is the manuscript presented in an intelligible fashion and written in standard English? PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here. Reviewer #1: Yes Reviewer #2: Yes ********** 5. Review Comments to the Author Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters) Reviewer #1: Thank you for the interesting work done. Kindly please refer to my suggestions below: General points It would be appropriate to separately summarise the findings of quantitative studies conducted in Nepal related to the topic in the introduction section. A reasonable rationale for conducting this study is required. The objective of this study is not clearly mentioned. Under the objective, it says the authors sought to understand the implication of the relationship between service seekers and health workers as well as the influence of clinic environment in immunisation service uptake. Next, it is stated that it would like to address barriers at the nexus of both demand and supply sides. Finally, it has also talked about the aim of the Rejoice Architecture Project. However, the abstract of this study stated a very specific objective – to understand the barriers to and facilitators of immunisation in Makwanpur from both the demand and supply sides. Then coming to the result section, it is again not clear what are the themes actually about. Understandably, barriers and facilitators can be included under the same theme under the demand and supply side. However, themes are not reflective of results most often. For instance, while the first theme looks like it only tries to include the facilitators of immunisation uptake, perspectives from both the demand and supply sides are included. If it is to be presented this way, then the authors should not confuse the demand side with the quote from health workers (as the authors mentioned in lines 230 to 231 that demand side of data is collected from family members' perspectives and supply-side from health workers or representatives' perspectives). Alternatively, based on the title of this study, separate headings on facilitators and barriers and themes within those headings could be done. Overall, there appeared to be a poorly consistent flow through the objectives, results, discussion, and conclusion. The discussion and conclusion section should be coherently organised as per the objective of the study and rewritten. Also, the authors should mention why there are no quotes from fathers at all. Was the information not at all noteworthy? It should be explained in the manuscript. More detailed comments: Introduction Line 59 – NIP, in 1977, was introduced as an immunisation program in the country, not to address inequities in vaccine coverage. Line 84 – reference number 13 is not appropriate to cite here as it was carried out in Kenya. Also, reference 12 focused on vaccines scheduled to be completed by 12 months of age. Would you please cite the appropriate reference here? Lines 115 to 116: "In Nepal, health facilities are often crowded, have inadequate waiting spaces if any at all, and are often unclean." It is such a generalised sentence. It should either have a precise citation or should be removed. Methodology Although a qualitative method is stated, no specific study design has been mentioned. Would you please keep the heading study design and mention it? Lines 131 to 132 – Being accessible from Kathmandu doesn't make it suitable for the research. The other two reasons are quite fair. Line 135 – I wonder why individuals living within a 1 km radius of health facilities were only eligible participants as the distance to health facilities could be a barrier, especially in hilly regions of Nepal. Line 138 - Are there any reasons why mothers were not included in in-depth interviews? Line 172 – Data collection procedure?? Also, please mention the data collection period as it could be valuable data. Lines 190 to 192 – Could you please associate the reference cited with this study? If not, you need to mention the procedure here clearly. Lines 195 to 197– Providing enough context and clarity doesn't justify why member checking was not done to increase the credibility of the research. Line 199 – Does it mean each interview and focus group discussion covered a separate topic? If so, it limits the transferability of the research. Can you please explain? Line 200 – The instruments should only be a guideline. It is not clear whether there was a separate guideline for each topic. Also, please include interview guidelines as an additional file. Results Line 307 - Here, the gender norm of women being the primary caretaker does not justify being a facilitating factor to increase vaccine coverage. Instead, the link between women receiving immunisation awareness when participating in mothers' groups and being the child's primary caretaker increased the likelihood of vaccinating their child. Line 344 – The last paragraph within this sub-theme is more of accountability issue and mistrust as represented by the theme, not a power imbalance. Line 364 – Is 5-hours a regular office opening hours, or was it because of the absence of health workers in the facilities to provide service. Immunisation has been covered mainly as an outreach service in communities in Nepal. Does the above-mentioned service hour refer to it? Would you please address this clearly? Line 380 to 383 – It is not acceptable to include information from the researcher's perspective in the result section, especially in this type of study. If it is explained based on the participants' response, please remove "Generally speaking" and support this claim with participants' quote. Line 384 to 389 – This is going out of context unless linked with the study's objective. Are they talking about addressing adverse effects of immunisation or the mistrust due to previous experiences on immunising their child? Or are they just expressing their other concerns related to health care services? Line 394 – This sentence does not reflect the essence of the quote here. It is more about not getting other services if not fully vaccinate their child. Refusing to immunise a child by health worker is a sensitive claim, and therefore a quote is required. Line 431 – Why family planning devices is affecting immunisation efforts? Line 445 to 453 – Why the results are not linked with immunisation here? It looks more like an interview related to the condition of the health care facility rather than how the health facility environment affects vaccine uptake. Line 454 – Provider or Provider’s Discussion Line 518 – Time hasn't been explained clearly as a barrier in the result section in the way it is mentioned here in the discussion. Line 524 to 526 – It is expressed from the key informants on the supply side rather than the family caregiver in the result section. It is misleading. Overall, the discussion should be coherently organised as per the objective of the study and rewritten. Limitations Line 588 to 589 – "It is also a fertile district able to grow and export cash crops to neighbouring cities of 589 Kathmandu and Hetauda" – This sentence has nothing to do with this study unless the socio-economic status of study participants is linked with vaccine uptake. There could be more limitation – one could be member checking (as mentioned earlier) - Including participants within 1 km radius excluded participants who could be affected by travel time to health facilities - No information is provided about the participants' backgrounds. It would be worthy of increasing the transferability of the study findings. - Was the number of participants finalised beforehand? Or was it based on data saturation? Conclusion Line 594 – "stocking adequate doses of vaccines" - not mentioned in the result section and, therefore, cannot be included in the conclusion Line 595 – "people's perceptions that many others do not fully vaccinate their children" – How is this a barrier? And why is it on conclusion rather than other important barriers discussed in the result section? Line 596 – "feelings of experienced disrespect" – What does this mean? Line 608 – There's nowhere in the results section that travel time is a barrier. Line 617 – Who are these marginalised groups? There is no identification of marginalised groups' deviant behaviours in the results. Overall, the conclusion should be rewritten. Reviewer #2: The manuscript is overall well written, based on findings from the field in one district of Nepal. This is recent work and as such it showcases situation of immunization after Nepal adopted provincial system of governance in 2015. This study is one of a very few detailed assessments of state of immunization in Nepal in recent years. The sample size is somewhat an issue, given the information that the work is trying to capture. The one district (out of 77 in the country) that was chosen is in close proximity to the capital of Nepal, Kathmandu and as such it may not truly represent the situation prevalent in rest of Nepal. Further, only three palikas were chosen with very limited sample size. The authors should make sure that this is identified as a major limitation of the study, as the current title of the study and its objectives do not match the results provided. Perhaps the title and objectives of the study should be revised to truly reflect the work carried out. ********** 6. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files. If you choose “no”, your identity will remain anonymous but your review may still be made public. Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy. Reviewer #1: No Reviewer #2: Yes: Sameer M Dixit [NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.] While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org. Please note that Supporting Information files do not need this step. |
| Revision 1 |
|
PONE-D-21-16867R1The last stretch: Barriers to and facilitators of full immunization among children in Nepal’s Makwanpur District, results from a qualitative studyPLOS ONE Dear Dr. Paul, Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a slightly revised version of the manuscript that addresses the points raised during the review process by Reviewer #1 (only one review was sought). I, as the Academic Editor, concur with Reviewer #1. I also carefully reviewed your revision that, I believe, was responsive to the reviews of your original submission. Now only a few suggested modifications are pending with you prior to revision and resubmitting. Please submit your revised manuscript by Jan 16 2022 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file. Please include the following items when submitting your revised manuscript:
If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: https://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols. Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols. We look forward to receiving your revised manuscript. Kind regards, Andy Stergachis, PhD Academic Editor PLOS ONE Journal Requirements: Please review your reference list to ensure that it is complete and correct. If you have cited papers that have been retracted, please include the rationale for doing so in the manuscript text, or remove these references and replace them with relevant current references. Any changes to the reference list should be mentioned in the rebuttal letter that accompanies your revised manuscript. If you need to cite a retracted article, indicate the article’s retracted status in the References list and also include a citation and full reference for the retraction notice. [Note: HTML markup is below. Please do not edit.] Reviewers' comments: Reviewer's Responses to Questions Comments to the Author 1. If the authors have adequately addressed your comments raised in a previous round of review and you feel that this manuscript is now acceptable for publication, you may indicate that here to bypass the “Comments to the Author” section, enter your conflict of interest statement in the “Confidential to Editor” section, and submit your "Accept" recommendation. Reviewer #1: All comments have been addressed ********** 2. Is the manuscript technically sound, and do the data support the conclusions? The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented. Reviewer #1: Yes ********** 3. Has the statistical analysis been performed appropriately and rigorously? Reviewer #1: N/A ********** 4. Have the authors made all data underlying the findings in their manuscript fully available? The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified. Reviewer #1: Yes ********** 5. Is the manuscript presented in an intelligible fashion and written in standard English? PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here. Reviewer #1: Yes ********** 6. Review Comments to the Author Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters) Reviewer #1: I highly appreciate the authors’ for thoroughly revisiting the manuscript as required. I have very few minor disagreements. 1. Line 84 I still disagree that this sentence—Nepal requires seven separate visits over 15 months to complete the full schedule [12,13]—is a generalised sentence that represents results from other low- and middle-income countries as it specifically mentions about Nepal. Therefore, I would suggest to either remove the citation from Kenya or make the sentence more generalised. 2. Line 178 The title of this section is only ‘Procedure’. As it is the data collection procedure, it would be better to have the clear title for this section. 3. The same information is repeated in line 254 (generational shift in attitudes toward immunization) and line 256. Please avoid repeating the same information, especially within the same section. ********** 7. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files. If you choose “no”, your identity will remain anonymous but your review may still be made public. Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy. Reviewer #1: No [NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.] While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org. Please note that Supporting Information files do not need this step. |
| Revision 2 |
|
The last stretch: Barriers to and facilitators of full immunization among children in Nepal’s Makwanpur District, results from a qualitative study PONE-D-21-16867R2 Dear Dr. Paul, We’re pleased to inform you that your manuscript has been judged scientifically suitable for publication and will be formally accepted for publication once it meets all outstanding technical requirements. Within one week, you’ll receive an e-mail detailing the required amendments. When these have been addressed, you’ll receive a formal acceptance letter and your manuscript will be scheduled for publication. An invoice for payment will follow shortly after the formal acceptance. To ensure an efficient process, please log into Editorial Manager at http://www.editorialmanager.com/pone/, click the 'Update My Information' link at the top of the page, and double check that your user information is up-to-date. If you have any billing related questions, please contact our Author Billing department directly at authorbilling@plos.org. If your institution or institutions have a press office, please notify them about your upcoming paper to help maximize its impact. If they’ll be preparing press materials, please inform our press team as soon as possible -- no later than 48 hours after receiving the formal acceptance. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org. Kind regards, Andy Stergachis, PhD Guest Editor PLOS ONE Additional Editor Comments (optional): This is a improved revision, fully responsive to suggested edits proposed by the reviewer with concurrence from the Guest Editor. Reviewers' comments: |
| Formally Accepted |
|
PONE-D-21-16867R2 The last stretch: Barriers to and facilitators of full immunization among children in Nepal’s Makwanpur District, results from a qualitative study Dear Dr. Paul: I'm pleased to inform you that your manuscript has been deemed suitable for publication in PLOS ONE. Congratulations! Your manuscript is now with our production department. If your institution or institutions have a press office, please let them know about your upcoming paper now to help maximize its impact. If they'll be preparing press materials, please inform our press team within the next 48 hours. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information please contact onepress@plos.org. If we can help with anything else, please email us at plosone@plos.org. Thank you for submitting your work to PLOS ONE and supporting open access. Kind regards, PLOS ONE Editorial Office Staff on behalf of Dr. Andy Stergachis Guest Editor PLOS ONE |
Open letter on the publication of peer review reports
PLOS recognizes the benefits of transparency in the peer review process. Therefore, we enable the publication of all of the content of peer review and author responses alongside final, published articles. Reviewers remain anonymous, unless they choose to reveal their names.
We encourage other journals to join us in this initiative. We hope that our action inspires the community, including researchers, research funders, and research institutions, to recognize the benefits of published peer review reports for all parts of the research system.
Learn more at ASAPbio .